Lb Pharmaceuticals LBRX
NASDAQ LBRX
$38.38 +1.10 (+2.95%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lb Pharmaceuticals (LBRX) Net Cash Flow (2024 - 2026)

Updated

Lb Pharmaceuticals' Net Cash Flow came in at -$37.55 million for Q2 2026, compared with -$5.6 million a year earlier.

Analysis

Lb Pharmaceuticals (LBRX) Net Cash Flow (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Lb Pharmaceuticals reported Net Cash Flow of $269.16 million; for FY2025, it was $227.47 million.

  • Going back by year, Net Cash Flow was $8.5 million in FY2024.
  • Business Quant data shows LBRX's Net Cash Flow at $70.5 million (Q1 2026), -$19.31 million (Q4 2025) and $255.52 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -1.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -2.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.53 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 757.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.62 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -4.43 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -722.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 652.90 Mn
10 Lb Pharmaceuticals 1.10 Bn 1.10 Bn - -37.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.55 Mn
Mar 31, 2026 70.50 Mn
Dec 31, 2025 -19.31 Mn
Sep 30, 2025 255.52 Mn
Jun 30, 2025 -5.60 Mn
Mar 31, 2025 -3.15 Mn
Dec 31, 2024 7.87 Mn
API Access

Lb Pharmaceuticals Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=LBRX&period=max&api_key=YOUR_API_KEY